IFF — International Flavors & Fragrances Inc.

IFF Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: Over $2.7 billion, reflecting a 3% increase year-over-year.
• Adjusted Operating EBITDA: $568 million, an 8% increase, with an adjusted EBITDA margin of 20.7%, the highest since Q2 2022.
• Segment Performance:
  • Health & Biosciences: Sales grew 5% to $595 million.
  • Taste: Sales increased 2% to $656 million, with a notable 18% rise in adjusted operating EBITDA to $153 million.
  • Food Ingredients: Sales up 3% to $839 million, with adjusted operating EBITDA increasing 12% to $114 million.
  • Scent: Sales grew 1% to $651 million, but adjusted operating EBITDA decreased 2% to $148 million due to unfavorable price-to-input costs.
• Cash Flow: Operating cash flow was $257 million, up $130 million year-over-year, with free cash flow of $92 million, an increase of $144 million.

2. Strategic Updates and Business Highlights

• IFF completed the divestiture of its commodity soy crush, concentrates, and lecithin business for $110 million, allowing focus on core growth areas.
• The company is enhancing its Health & Biosciences capabilities in Latin America with new production sites and innovation labs.
• Ongoing strong interest in the sale of the Food Ingredients business, with updates expected by the next earnings call.
• Continued investment in productivity initiatives, innovation, and customer partnerships to drive long-term growth.

3. Forward Guidance and Outlook

• IFF reaffirmed its full-year 2026 guidance, expecting sales between $10.5 billion and $10.8 billion (1% to 4% growth) and adjusted operating EBITDA between $2.05 billion and $2.15 billion (3% to 8% growth).
• Anticipated inflationary pressures, particularly in energy and logistics, may impact profitability in Q2, with expectations for gradual easing in the second half of the year.
• The company remains confident in its ability to navigate macroeconomic challenges, including the ongoing Middle East conflict.

4. Bad News, Challenges, or Points of Concern

• The Scent segment, particularly Fine Fragrance, is facing challenges due to market softness and supply chain issues related to the Middle East conflict.
• Inflationary pressures are expected to build throughout 2026, with potential adverse impacts on profitability in Q2 before pricing actions take effect.
• The company noted that while Q1 was strong, the outlook for Q2 is more cautious due to these challenges.

5. Notable Q&A Insights

• Management indicated that Q1 outperformance was primarily driven by volume growth and productivity, with no significant evidence of prebuying from customers.
• The divestiture process for the Food Ingredients business is progressing well, with positive feedback from potential buyers.
• Pricing discussions with customers are ongoing, with a focus on passing through cost increases without significantly impacting demand.
• Management is optimistic about the second half of the year, expecting improvements in health trends and continued strength in innovation pipelines across segments.

Overall, IFF's Q1 2026 results reflect solid performance amid a challenging macroeconomic environment, with a focus on strategic growth and operational efficiency.